Application Note

A Transient Cell Line To Produce rAAV With Low-Level hcDNA Encapsidation

Source: Cytiva

Recombinant adeno-associated virus (rAAV) manufacturing is undergoing a significant transformation, with stable producer cell lines emerging as the primary cell factories of the future. However, transitioning to producer cell lines is a nuanced process, necessitating the utilization of transient transfection cell lines that prioritize speed and flexibility. To meet these requirements, a novel human embryonic kidney (HEK) 293 suspension cell line has been developed. The line ELEVECTA™ transient cell line is designed to integrate seamlessly into diverse research workflows and large-scale GMP production. Here, we showcase its ability for efficient and scalable rAAV production across various serotypes with low encapsidated host cell DNA (hcDNA) levels.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online